Tagros to acquire Bayer's global flubendiamide business

This strategic acquisition provides Tagros with access to markets across more than 25 countries

Tagros Chemicals India Private Limited signed a definitive agreement to acquire the global assets of Bayer AG’s Flubendiamide (FLB) active ingredient business. This strategic deal covers operations across the LATAM, EMEA, and APAC regions.

As part of the transaction, Tagros will acquire Solo and Mixture Formulations related to the active ingredient, along with a comprehensive suite of business assets, including trademarks (BELT, FAME, FENOS, FENOS QUICK, BELT EXPERT, and TIHAN), product registrations and registration data, product information, formulation know-how, technical information, and inventories associated with the FLB business.

This strategic acquisition provides Tagros with access to markets across more than 25 countries, significantly strengthening its global footprint and reinforcing its position in the Diamide segment.

This acquisition also represents a significant milestone for Tagros, marking its strategic entry into the B2C formulations business, which will be housed under its recently established entity, Arqivo. EY India acted as the M&A advisor to Tagros while Khaitan & Khaitan served as legal advisor.